ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 269721 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 269721; 2) Community: the network communities that were significantly associated with the response to NSC 269721; 3) Molecule: the relationships between components within communities and NSC 269721; 4) MDR: the compounds that were significantly associated with the NSC 269721.

NSC Compound Enrichment Correlation
NSC 704637 Null 0.0414190425892871 0.29921841
NSC 705437 Null 0.0414190425892871 0.6299765
NSC 715584 Null 0.0414190425892871 0.09948213
NSC 717842 Acetamide, 2-[[[2-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)- 1,2-dihydro-3H-indol-3-ylidene]amino]oxy]-, (2Z)- 0.0414190425892871 0.078789595
NSC 745591 Null 0.0414190425892871 0.078786235
NSC 754240 2,9-dimethoxy-6-(2-(piperidin-1-yl)ethoxy)-11H-indeno[1,2-c]quinolin-11-one 0.0414190425892871 0.42618473
NSC 226080 Sirolimus 0.0415729612483928 0.1713648
NSC 267319 Null 0.0415729612483928 -0.012998164
NSC 307241 Adriamycin deriv., mixt. with hydroxyethyl starch (cross-linked) 0.0415729612483928 0.39418397
NSC 613662 Null 0.0415729612483928 0.091952593
Total:61  Current:50    [First] [Prev] [Next] [Last]